19.3 C
New York
Tuesday, September 21, 2021

Wall Street’s Key Stock Analysts Research Report, All Buys

#stocks #bullish #buys #analysts #research #WallStreet


Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy if you can manage the risk.

These are all Buys if you can manage the risk.

Below are our Buys for Friday, 26 February, as follows:

AstraZeneca Inc. (NASDAQ:AZN) was raised to Buy from Neutral at UBS. The shares have traded in a 52-wk range of 36.15 – 64.94 and have a consensus price target of 62.35.

Lowe’s Companies Inc. (NYSE:LOW) was raised to Buy from Accumulate at Gordon Haskett, which has a 202 price target on the retail home improvement giant. The consensus target is at 162.31.

Newmark Group Inc. (NASDAQ:NMRK) was raised at BofA Securities from Underperform to Buy with a 20 price target. The consensus target is at 9.83.

Nike Inc. (NYSE:NKE) was upgraded to Buy from Hold at HSBC Securities, which raised the price target on the shoe and apparel leader to 158. The consensus target is higher at 162.65.

Square Inc. (NYSE:SQ) was raised from Neutral to Buy with a 288 price target at Guggenheim. The consensus target is at 264.05.

Have a healthy day, Keep the Faith!

Paul Ebeling
Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   

Related Articles

Stay Connected

- Advertisement -spot_img

Latest Articles